Clinical trials lead to new treatments

December 9, 2016

When Amy Charney was diagnosed with HER-2 positive breast cancer in November 2014, she told Lisa Carey, MD, she preferred a therapy that would allow her to continue her active life as a mom, wife and avid runner. Dr. Carey identified a clinical trial for Amy was eligible, and is happy to report the novel treatment proved to be effective and have fewer side-effects.

Donors’ matching gift challenge raises more than $250,000

December 9, 2016

UNC Lineberger donors have demonstrated the power of matching gift challenges. An anonymous coupled pledged to match every gift, dollar for dollar, up to $50,000,and within two weeks, the cancer center received $50,000 in matching gifts. After hearing about the campaign’s success, UNC Lineberger Board of Visitors members Bill and Nancy Graham were inspired to issue an additional $50,000 challenge, effectively quadrupling the gift.

Faculty profile: Drs. Marks and Hertz pay it forward

December 9, 2016

Larry Marks, MD, Chair, Radiation Oncology and the Dr. Sidney K. Simon Distinguished Professorship of Oncology Research at UNC Lineberger, and Caryn Hertz, MD. Caryn M. Hertz, MD, associate professor of Anesthesiology at UNC School of Medicine, say they have always made philanthropy a part of their family’s lives, including their financial support of UNC Lineberger.

Immunotherapy: Breaking barriers, beating cancer

December 9, 2016

Janet Mazzurco was diagnosed with melanoma seven years ago, which later developed into stage IV metastatic disease. Fran Collichio, MD, began treating Janet with a checkpoint inhibitor drug called ipilimumab and her disease is now in remission.

Ken and Cheryl Williams make $10 Million gift to advance cancer research

December 9, 2016

Ken and Cheryl Williams made a $10 million gift to UNC Lineberger to fund cancer research initiatives that hold the greatest promise for cures. With the memories of the pain they experienced when their son Tony passed away, they hope the research will result in clinical advances and save other families from suffering the loss of a loved one.

Lab naming honors She ROCKS founder

December 9, 2016

When Beth Quinn was diagnosed with stage IV ovarian cancer, she and her friends made a commitment to make a difference. They formed She ROCKS to raise funds for ovarian cancer research and patient support. The group has contributed more than $170,000 to fund the ovarian cancer research of UNC Lineberger’s Vicki Bae-Jump, MD, PhD. This past September, UNC Lineberger renamed part of Bae-Jump lab space in Beth’s honor.

Monty and Nancy White: Putting down roots, planting the seeds of discovery

December 9, 2016

In 2003, Monty and Nancy White established the White Seed Grant Fund to provide seed grant support for UNC Lineberger faculty research. The couple agrees it is one of the smartest investments they’ve ever made, and they envision a day when the seed grant funding will spark a discovery that leads to a cure.

The AYA Program: Bridging the gap to ‘no man’s land’

December 9, 2016

Around the world, there is a growing appreciation of the unique needs of teenagers and young adults who have cancer. Unfortunately, there are still huge gaps in terms of their personalized psychosocial care. UNC Lineberger has teamed up with the Be Loud! Sophie Foundation to change that.

Valvano honored for work to fight cancer

December 9, 2016

At its 2nd Blue Ribbon Gala in September 2015, UNC Lineberger honored a number of it supporters who have made significant contributions in the fight against cancer, including Nicholas Valvano, president emeritus of The V Foundation for Cancer Research.

Vs. Cancer funds pediatric cancer research

December 9, 2016

Chase Jones, who was successfully treated for stage IV brain cancer at UNC Lineberger, started the Vs. Cancer Foundation with the goal of fundraising for pediatric cancer research and supporting the needs of patients and families during treatment. Since 2013, Vs. Cancer has provided UNC Lineberger with more than $245,000 in grants, including the most recent gift of $115,000 to support pediatric cellular immunotherapy trials and research, and specifically, the work of Barbara Savoldo, MD, PhD.